Target intelligence / Profile preview

Ribosomal protein L29 pseudogene 1 (RPL29P1)

Target
RPL29P1
Molecular classification
Other (Pseudogene)
01

Overview

Ribosomal protein L29 pseudogene 1 (RPL29P1) is a processed pseudogene of the ribosomal protein L29 gene, meaning it is a non-functional genomic DNA sequence derived from the functional gene. It does not encode an active protein and has no known direct biological function or disease role. Pseudogenes like RPL29P1 arise from duplication or retrotransposition events of functional genes and are widespread in genomes, especially for ribosomal protein gene families. RPL29P1 is not a receptor, enzyme, transporter, or viable drug target and is not used as a biomarker. It should not be conflated with the functional ribosomal protein L29 (RPL29), which is a structural component of the 60S ribosomal subunit involved in protein synthesis[3][5][6].\n\nKey context:\n- RPL29P1 is listed in gene databases under pseudogenes and does not encode a functional protein[3][6].\n- Pseudogenes are non-coding; their roles (if any) are generally regulatory, but RPL29P1 itself is not known to have such a function[5].\n- There are no drugs, mechanisms of action, or safety concerns associated with RPL29P1.\n- Any therapeutic or functional information about "ribosomal protein L29" refers to the functional gene/product RPL29, not to RPL29P1.\n\nSummary: \nRPL29P1 is not a valid therapeutic target, but a processed pseudogene—essentially an inactive genomic relic without a direct functional or disease role[3][5][6]. Any information regarding ribosomal protein L29 function or disease links must refer to RPL29, the protein-coding gene, not its pseudogenes.

Other names
dJ336K20B.2RPL29_5_654RPL29P1 ribosomal protein L29 pseudogene 1RPL29P1

Beyond the preview

Go deeper on Ribosomal protein L29 pseudogene 1 (RPL29P1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein L29 pseudogene 1 (RPL29P1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call